Assembly Biosciences, Inc. is a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel oral biotherapeutics for disorders associated with the microbiome.

NEWS

See all news

Events

June 26, 2017
June Investor Presentation
June 07, 2017
Jefferies 2017 Global Healthcare Conference